UnitedHealth Group Returns to Profit with Adjusted Earnings Outlook Revised
UnitedHealth Group reports a return to profitability in Q1 2025 with $6.4B net earnings, revises 2025 earnings outlook amid Medicare Advantage and Optum challenges.
UnitedHealth Group reports a return to profitability in Q1 2025 with $6.4B net earnings, revises 2025 earnings outlook amid Medicare Advantage and Optum challenges.
Medicare Advantage enrollment growth slows in 2025 with for-profit plans covering three-quarters of beneficiaries. Quality ratings decline and workforce shortages drive interest in advanced practice providers and AI solutions.
CMS finalizes key elements of the CY 2026 Medicare Advantage and Medicare Part D final rule, including insulin coverage expansion, Prescription Payment Plan codification, pharmacy data requirements, and updated enrollee protections.
CMS increases 2026 Medicare Advantage reimbursement rates to 5.06%, easing insurer pressures while adjusting policies on obesity drug coverage and billing practices.
UnitedHealth Group's Q1 2025 earnings reveal increased Medicare Advantage care utilization and regulatory payment changes impacting financial performance, highlighting challenges in the evolving health insurance market.
Discover why UnitedHealth Group's stock experienced its largest decline in over 20 years following Q1 earnings that fell short of Wall Street expectations. Learn more about the factors influencing its financial performance and future outlook.
In upstate New York, Medicare Advantage plan beneficiaries face possible cuts in benefits and increases in costs due to changes in the Medicare wage index. Learn about the legislative efforts to mitigate this issue.
The CMS final rule effective 2026 will modernize Medicare Advantage and Part D, enhancing drug coverage and establishing more robust regulatory frameworks.
Regence BlueShield pulls Medicare Advantage plans from Asotin County, impacting hundreds of beneficiaries seeking new coverage options and highlighting issues in healthcare access and costs.
Humana's new $250M Fixed-Income Offering and partnership with Icon Health aim to enhance senior care and boost market performance, despite facing challenges in maintaining competitive growth and managing regulatory pressures.